Amanote Research

Amanote Research

    RegisterSign In

Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease

Frontiers in Neurology - Switzerland
doi 10.3389/fneur.2019.01087
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

October 15, 2019

Authors
Sebastiaan P. van KesselSahar El Aidy
Publisher

Frontiers Media SA


Related search

Gut Microbiota in Parkinson's Disease: Temporal Stability and Relations to Disease Progression

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Evaluating the Contributions of Dynamic Flow to Freezing of Gait in Parkinson's Disease

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2010English

Treatment of Parkinson's Disease

New England Journal of Medicine
Medicine
1994English

Treatment of Parkinson's Disease

New England Journal of Medicine
Medicine
1961English

The Association Between Mediterranean Diet Adherence and Parkinson's Disease

Movement Disorders
Neurology
2012English

Retracted: Obesity as a Consequence of Gut Bacteria and Diet Interactions

International Scholarly Research Notices
2015English

Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson's Disease

2019English

Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug–Drug and Drug–Disease Interactions

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2017English

Voice and Speech Treatment of Parkinson's Disease

Journal of allied health sciences
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy